Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
G. D'Haens,F. Baert,19 Authors,D. Hommes
2008 · DOI: 10.1016/S0140-6736(08)60304-9
The Lancet · 1,131 Citations
TLDR
Combined immunosuppression was more effective than conventional management for induction of remission and reduction of corticosteroid use in patients who had been recently diagnosed with Crohn's disease.